Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Taxeldix - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Taxeldix

Approved

STANDARD

Taxeldix

Eskayef Pharmaceuticals Limited-Rupganj Plant🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: d2272b7b210aa38c
Company: Eskayef Pharmaceuticals Limited-Rupganj Plant
Type: Standard

Approval Details

Approval Id: d2272b7b210aa38c
Drug Approval Philippines Name: Taxeldix
Product Name: Taxeldix
Registration Number: DRP-12602-02
Brand Name: Taxeldix
Generic Name: Paclitaxel
Dosage Form: Solution for Injection (IV Infusion)
Dosage Strength: 6 mg/mL (100 mg/16.7 mL)
Manufacturer: Eskayef Pharmaceuticals Limited-Rupganj Plant
Importer: Pharmakon Biotec Inc
Distributor: Zeldix Pharma Inc
Issuance Date: 24 April 2024
Expiry Date: 13 September 2027
Pharmacologic Category: Antineoplastic Agent (Taxane)
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

d2272b7b210aa38c

Type

Standard

Back to Philippines FDA Approvals